The differential role of NOS inhibitors on stress-induced anxiety and neuroendocrine alterations in the rat

Behavioural Brain Research

Volumn 235, Issue 2, 2012, Pages 176-181

  Joung, Hye Young ^a,b   Jung, Eun Yee ^b   Kim, Kyungsoo ^a   Lee, Mi Sook ^b   Her, Song ^c   Shim, Insop ^b  

^a The Catholic University of Korea   (South Korea)

^b Kyung Hee University   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

7 Nitroindazole (7 NI); Anxiety; Corticosterone; N Nitro l arginine methyl ester hydrochloride (l NAME); Nitric oxide synthase (NOS); Restraint stress

Indexed keywords

7 NITROINDAZOLE; CORTICOSTERONE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENZYME BLOOD LEVEL; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMOBILIZATION STRESS; LATENT PERIOD; LATERAL DORSAL TEGMENTAL NUCLEUS; LOCUS CERULEUS; MALE; MAZE TEST; NEUROENDOCRINE DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; TEGMENTUM;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BRAIN; CORTICOSTERONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INDAZOLES; MALE; MAZE LEARNING; NADP; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE SYNTHASE; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RESTRAINT, PHYSICAL;

EID: 84865335649     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.07.037     Document Type: Article

References (41)

1. Heinrichs S.C., Menzanghi F., Pich E.M., Baldwin H.A., Rassnick S., Britton K.T., et al. Anti-stress action of corticotrophin-releasing factor antagonist on behavioral reactivity to stressors of varying types and intensity. Neuropsychopharmacology 1994, 11:179-186.
2. Madrigal J.L.M., Olivia H.O., Moro M.A., Lizasoain I., Lorenzo P., Castrillo A., et al. The increase in TNF-α levels is implicated in NF-κB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology 2002, 26:155-163.
3. Tsuchiya T., Kishimoto J., Koyama J., Ozawa T. Modulatory effect of L-NAME, a specific nitric oxide synthase inhibitor, on stress-induced changes in plasma adrenocorticotropic hormone and cortico-sterone levels in rats: physiological significance of stress-induced NOS activation in hypothalamic-pituitary-adrenal axis. Brain Research 1997, 776:68-74.
4. Bredt D.S., Glatt C.E., Hwang P.M., Fotuhi M., Dawson T.M., Snyder S.H. Nitiric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 1991, 7:615-624.
5. Calza L., Giardino L., Ceccatelli S. NOS mRNA in the paraventricular nucleus of young and old rats after immobilization stress. NeuroReport 1993, 4:627-630.
6. Dawson T.M., Dawson V.L. Ntiric oxide synthase: role as a transmitter/mediator in the brain and endocrine system. Annual Review of Medicine 1996, 47:219-227.
7. Mcleod T.M., Lopez-Figueroa A.L., Lopez-Figueroa M.O. Nitric oxide, stress and depression. Psychopharmacology Bulletin 2001, 35:24-41.
8. Costa A., Trainer P., Besser M., Grossman A. Nitric oxide modulates the release of corticotrophin-releasing hormone from the rat hypothalamus in vitro. Brain Research 1993, 605:187-192.
9. Lopez-Figueroa M.O., Itoi K., Watson S.J. Regulation of nitric oxide synthase messenger RNA expression in the rat hippocampus by glucocorticoids. Neuroscience 1998, 87:439-446.
10. Masood A., Banerjee B., Vijayan V.K., Ray A. Modulation of stress-induced neurobahavioral changes by nitric oxide in rats. European Journal of Pharmacology 2003, 458:135-139.
11. Harkin A.J., Bruce K.H., Craft B., Paul I.A. Nitric oxide synthase inhibitors have antidepressant-like properties in mice, 1. Acute treatments are active in the forced swim test. European Journal of Pharmacology 1999, 327:207-213.
12. Yildiz F., Ulak G., Erden B.F., Gacar N. Anxiolytic-like effects of 7-nutroindazole in the plus-maze test. Pharmacology Biochemistry and Behavior 2000, 65:199-202.
13. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods 1985, 14:149-167.
14. Matata B.M., Galiñanes M. Effect of diabetes on nitric oxide metabolism during cardiac surgery. Diabetes 2001, 50:2603-2610.
15. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2009, Elsevier, Amsterdam. compact 6th ed.
16. Faria M.S., Muscara M.N., Moreno, Junior H., Teixeira S.A., Dias H.B., De Oliveria B., Graeff F.G., De Nucci G. Acute inhibition of nitric oxide synthesis induces anxiolysis in the plus maze test. European Journal of Pharmacology 1997, 323:37-43.
17. Guimaraes F.S., de Aguiar J.C., Del Bel E.A., Ballejo G. Anxiolytic effect of nitric oxide inhibitors microinjectied in to the dosal central grey. NeuroReport 1994, 5:1929-1932.
18. Harkin A., Connor T.J., Walsh M., St John N., Kelly J.P. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacology 2003, 44:616-623.
19. Lacza Z., Puskar M., Figueroa J.P., Zhang J., Rajapakse N., Busija D.W. Mitochondrial nitric oxide synthase is constitutively active and is functionally upregulated in hypoxia. Free Radical Biology & Medicine 2001, 31:1609-1615.
20. Breard M., Sari M.A., Frapart Y., Boucher J.-L., Ducrocq C., Grillon C. The endogenous neurotransmitter, serotonin, modifies neuronal nitric oxide synthase activities. Free Radical Research 2007, 41:413-423.
21. Gulati K., Ray A., Masood A., Vijayan V.K. Involvement of nitric oxide (NO) in the regulation of stress susceptibility and adaptation in rats. Indian Journal of Experimental Biology 2006, 44:809-815.
22. Kim C.K., Rivier C. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine response to peripheral immune signals. Journal of Neuroendocrinology 1998, 10:353-362.
23. Rivier C. Blockade of nitric oxide formation augments adrenocorticotropin released by blood-borne interlukin-1 beta: role of vasopressin, prostaglandins, and alpha 1-adrenergic receptors. Endocrinology 1995, 136:3597-3603.
24. Nelson R.J., Kriegsfeld L.J., Dawson V.L., Dawson T.M. Effects of nitric oxide on neuroendocrine function and behavior. Frontiers in Neuroendocrinology 1997, 18:463-491.
25. Bryan N.S., Grisham M.B. Methods to detect nitric oxide and its metabolites in biological samples. Free Radical Biology & Medicine 2007, 43:645-657.
26. Amir S., Rackover M., Frunk D. Blockers of nitric oxide synthase inhibit stress activation of c-fos expression in neurons of the hypothalamic paraventricular nucleus in the rat. Neuroscience 1997, 77:623-627.
27. Esplugues J.V. NO as a signaling molecule in the nervous system. British Journal of Pharmacology 2002, 135:1079-1095.
28. Kiss J.P. Role of nitric oxide in the regulation of monoaminergic neurotransmission. Brain Research Bulletin 2000, 52:459-466.
29. Lei S.Z., Pan Z.H., Aggarwal S.K., Chen H.S., Hartman J., Sucher N.J., Lipton S.A. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 1992, 8:1087-1099.
30. Sinner C., Kaehler S.T., Philippu A., Singewald N. Role of nitric oxide in the stress-induced release of serotonin in the locus coeruleus. Naunyn-Schmiedeberg's Archives of Pharmacology 2001, 364:105-109.
31. Heiberg I.L., Wegener G., Rosenberg R. Reduction of GMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behavioural Brain Research 2002, 134:479-484.
32. Girgin Sagin F., Sozmen E.Y., Ersoz B., Mentes G. Link between monoamine oxidase and nitric oxide. Neurotoxicology 2004, 25:91-99.
33. Kodama T., Koyama Y. Nitric oxide from the laterodosal tegmental neurons: its possible retrograde modulation on norepinephrine release from the axon terminal of the locus coeruleus neurons. Neuroscience 2006, 138:245-256.
34. Harkin A., Connor T.J., Burns M.P., Kelly J.P. Nitric oxide inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. European Neuropsychopharmacology 2004, 14:274-281.
35. Joca S.R., Padovan C.M., Guimaraes F.S. Activation of postsynaptic 5-HT1A receptors in the dorsal hippocampus prevents learned helplessness development. Brain Research 2003, 978:177-184.
36. Canossa M., Giordano E., Cappello S., Guarnieri C., Ferri S. Nitric oxide down-regulates brain-derived neurotrophic factor secretion in cultured hippocampal neurons. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:3282-3287.
37. Lee J., Duan W., Mattson M.P. Evidence that brain derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. Journal of Neurochemistry 2002, 82:1367-1375.
38. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Archives of General Psychiatry 1997, 54:597-608.
39. Malberg J.E., Duman R.S. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 2003, 28:1562-1571.
40. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
41. Chrousos G.P. Stressor stress and neuroendocrinology intergration of the adaptive response. The 1997 Hans Selye Memorial lecture. Annals of the New York Academy of Sciences 1998, 851:311-335.